What does chronic rhinosinusitis with nasal polyps (CRSwNP) mean?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: February 16, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

What Does CRS with Nasal Polyps Mean?

Chronic rhinosinusitis with nasal polyps (CRSwNP) is a chronic inflammatory disease of the nasal passages and paranasal sinuses lasting at least 12 weeks, characterized by the presence of bilateral, endoscopically visible polyps in the middle meatus, along with symptoms of nasal blockage and/or nasal discharge. 1

Diagnostic Criteria

CRSwNP requires both symptomatic and objective confirmation 2:

Symptomatic Requirements (≥12 weeks duration)

  • At least two symptoms must be present, with one being mandatory: 1

    • Nasal blockage/obstruction/congestion (mandatory symptom) OR
    • Nasal discharge—anterior or posterior nasal drip (mandatory symptom)
  • Plus optional symptoms: 1

    • Facial pain/pressure
    • Reduction or loss of smell

Objective Confirmation

  • Bilateral, endoscopically visualized polyps in the middle meatus 1
  • The polyps must be pedunculated lesions, not just cobblestoned mucosa 1
  • If necessary, examination should be performed following decongestant application 1

Key Distinguishing Features

CRSwNP is distinct from CRS without nasal polyps (CRSsNP), which has the same symptom criteria but no visible polyps in the middle meatus on endoscopic examination 1. This classification is critical because the two conditions have different underlying inflammatory mechanisms and treatment responses 1, 3.

Underlying Disease Mechanism

CRSwNP is predominantly a type 2 inflammation-mediated disease involving the nasal mucosa and paranasal sinuses 3. The condition represents a spectrum of disease that includes polypoid changes in the sinuses and/or middle meatus, but specifically excludes polypoid disease presenting only in the nasal cavity to avoid diagnostic overlap 1.

Clinical Impact

Patients with CRSwNP experience significant disease burden 3:

  • High symptom burden including nasal congestion, loss of smell, and rhinorrhea
  • Negative impact on physical and mental health-related quality of life
  • Sleep quality impairment
  • Frequent recurrence even after medical and surgical interventions

Common Comorbidities

Important associated conditions to assess include: 1

  • NSAID-exacerbated respiratory disease (N-ERD/aspirin sensitivity)
  • Asthma or bronchial hyperreactivity
  • Allergic conditions based on specific IgE or skin prick testing
  • Elevated total serum IgE levels

These comorbidities are relevant because type 2 inflammation is implicated in multiple coexisting diseases, and patients with these conditions often have more severe disease 3, 4.

Post-Surgical Definition

After sinus surgery has altered the lateral wall anatomy, polyps are defined as bilateral pedunculated lesions (not cobblestoned mucosa) observed more than 6 months after surgery on endoscopic examination 1. Any mucosal disease without overt polyps post-surgery should be classified as CRS without nasal polyps 1.

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Chronic Rhinosinusitis Diagnosis and Classification

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

Research

Burden of Disease in Chronic Rhinosinusitis with Nasal Polyps.

Journal of asthma and allergy, 2021

Research

Anti-IgE therapy in chronic rhinosinusitis with nasal polyps.

The Journal of allergy and clinical immunology, 2025

Related Questions

What is the efficacy of biologics such as dupilumab (dupilumab), benralizumab (benralizumab), or mepolizumab (mepolizumab) in the treatment of Chronic Rhinosinusitis with Nasal Polyps (CRSwNP)?
What is the FDA approval status of Tezspire (tezepelumab) for chronic rhinosinusitis with nasal polyps?
Is surgery medically indicated for a patient with chronic maxillary sinusitis, hypertrophy of nasal turbinates, and nasal polyp, who has tried Xhance (fluticasone), saline, Flonase (fluticasone), Astelin (azelastine), and Singulair (montelukast) with little relief and no documented 6 weeks of saline irrigations?
In a patient with chronic rhinosinusitis whose most bothersome symptom on the SNOT‑22 (SinoNasal Outcome Test‑22) is nasal congestion, what is the recommended treatment approach?
What is the comparative efficacy and safety of dupilumab (Dupixent) vs mepolizumab (Nucala) and omalizumab (Xolair) in chronic rhinosinusitis with nasal polyps (CRSwNP)?
What are the possible causes and recommended work‑up for a week‑long onset of numbness and tingling in my right hand without weakness or other red‑flag symptoms?
What is the recommended management for a fusiform dilatation of the ascending aorta measuring 4.1 × 3.8 cm?
How should I adjust therapy for a 44‑year‑old woman with type 2 diabetes mellitus, hypertension, and hyperlipidemia who has an HbA1c of 8 %, LDL‑cholesterol 112 mg/dL, triglycerides 283 mg/dL, normal estimated glomerular filtration rate, and is taking metformin extended‑release 1000 mg daily, glipizide extended‑release 10 mg daily, and atorvastatin 10 mg daily?
What type of insulin is Lantus (insulin glargine)?
Can a urinary‑tract infection be deemed resolved in a 66‑year‑old postmenopausal African American woman if the provider documented clearance despite persistent leukocyte esterase positivity, pyuria, bacteria on urinalysis and a negative or low‑count urine culture, without any recorded symptom assessment?
What is the recommended dosing schedule, contraindications, renal dose adjustment, monitoring parameters, and alternative therapy options for Otezla (apremilast) in an adult with moderate‑to‑severe plaque psoriasis (or active psoriatic arthritis) who is a candidate for systemic therapy?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.